PLCG1 and neoplasm: As shown in Figure 5A, tumor-bearing nude mice treated with neoantigen (ACAD8-T105I, BCAR1-G23V and PLCG1-M425L)-induced NRTs exhibited significantly delayed tumor growth, whereas the irrelevant peptide-induced NRTs did not restrict tumor growth.